Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity.

Area of Science:

• Neuroscience
• Decision Science
• Dopamine Research

Background:

• Decision-making relies on frontolimbic and dopaminergic pathways.
• Integration of choice outcomes, dopamine, and frontostriatal activity in decision-making remains unclear.

Purpose of the Study:

• To investigate how prior choice outcomes and dopamine neurotransmission influence frontostriatal activity during risk-taking.
• To explore the relationship between striatal dopamine D2/D3 receptor binding potential and risk-taking behavior.

Main Methods:

• Functional magnetic resonance imaging (fMRI) was used to monitor brain activity in 60 healthy volunteers during the Balloon Analogue Risk Task (BART).
• Positron emission tomography (PET) was employed to measure striatal D2/D3 dopamine receptor binding potential (BPND) in a subset of participants.
• Behavioral data on risk-taking choices and monetary earnings were collected.

Main Results:

• Participants made fewer risky choices after losses compared to wins.
• Amygdala and hippocampal activation showed greater modulation by risk level after losses.
• Striatal D2/D3 BPND correlated with ventral striatal activation during cash-out decisions and prefrontal cortical activation during risk-taking, influencing subsequent choices and overall earnings.

Conclusions:

• Prior outcomes significantly impact risk-taking behavior.
• Dopaminergic neurotransmission, indexed by striatal D2/D3 receptor availability, plays a crucial role in modulating risk-taking.
• An interactive system involving frontal and striatal activity, influenced by dopamine, underlies risk-modulated decision-making.